Nephroquin SRL
Nephroquin reported total assets of 455,578 € at the end of the 2025 financial year (annual accounts filed with the NBB on 01 Jul 2026).
The score of Nephroquin shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +64 % Total assets +88 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Nephroquin's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 108,172 € | ||||
| Equity | 327,980 € | ||||
| Cash | 339,814 € | ||||
| EBITDA | 166,502 € | ||||
| Total assets | 455,578 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 01 Jul 2026
- Year ended 31 Dec 2024filed on 05 Jul 2025
- Year ended 31 Dec 2023filed on 30 Jun 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 13 Jul 2022
Nephroquin's financial analysis
- Solvency72.0%sector median: 65.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Nephroquin
Nephroquin's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0721.598.242
- VAT number
- BE0721598242
- Peppol
- Registered · 0208:0721598242 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Feb 2019
- Registered office
- 4900 Spa
- Latest accounts
- 2025 · filed on 01 Jul 2026
- Activity
- General medical practice activities (NACE 86210)
Nephroquin (SRL) has been based in Spa since 2019, active in: general medical practice activities. For 2025, it reports a net profit of 108,172 € and equity of 327,980 €; its revenue is not published. Its solvency stands at 72.0%, above the median of its sector (65.8%).
Companies similar to Nephroquin
Companies in the same business, of comparable size and area, outside its group.
- Dr. Marike Leijs, Dermatology & Dermatosurgery General medical practice activities Eupen · balance sheet 569,739 €
- Ninanest General medical practice activities Chaudfontaine · balance sheet 346,063 €
- Eric Junker General medical practice activities Spa · balance sheet 341,859 €
- Docteur Philippe Leonard General medical practice activities Jette · balance sheet 373,371 €
- Medicilasne General medical practice activities Lasne · balance sheet 622,973 €
- Gacs Cabinet Medical General medical practice activities Ohey · balance sheet 454,653 €
- Cabinet Medical Mirland General medical practice activities Dour · balance sheet 459,322 €
- Dokter Van Compernolle Dries General medical practice activities Ghent · balance sheet 463,393 €
Frequently asked questions about Nephroquin
What is the revenue of Nephroquin?
Nephroquin files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Nephroquin?
In Belgium, the VAT number is the company number prefixed with BE: BE0721598242 for Nephroquin, if the company is VAT-registered. Its company number (CBE) is 0721.598.242.
Where is the registered office of Nephroquin?
According to the CBE register, the registered office of Nephroquin is in 4900 Spa.
What is the equity of Nephroquin?
At the close of the 2025 financial year, the equity of Nephroquin amounts to 327,980 €, a solvency of 72.0% of total assets.
Who manages Nephroquin?
The register lists 2 active mandates at Nephroquin. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Nephroquin
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →